Clinical Trials Directory

Trials / Completed

CompletedNCT02074969

Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures

Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures - Epidemiological Data and Rates of Complications

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the differences between two different types of devices for the treatment of unstable pertrochanteric hip fractures. The hypothesis of this study is, that patients who are treated with the proximal femoral Nail Antirotation (PFNA) have a better outcome and lower complication rates than patients treated with the Gamma Nail (GN3).

Detailed description

This trial is a prospective randomized controlled study including the treatment of AO/OTA 31-A2 fractures in 200 patients with 2 different surgical devices. 100 patients are treated with a Gamma Nail 3 (GN3) (Stryker) the other 100 patients with a Proximal Femoral Nail Antirotation (PFNA) (Synthes). All surgeries are performed by trauma surgeons at a Level 1 University Hospital. One hundred patients are randomized to the gamma nail and 100 are randomized to the proximal femoral nail for treatment fixation. A 1:1 randomization is performed using sealed envelopes (200 in total), which are opened by the surgeon immediately before the operation. Patients missing an informed consent form, incomplete chart, or showing a pathologic fracture are getting excluded from final comparisons. Patients anthropometric data as well as pre-injury mobility assessments, and ASA will be documented. Furthermore the time from admission to going to surgery, surgery length, length of stay and mobility assessment at dischargement are recorded. After surgery the stay in the hospital is documented precisely and patients are scheduled for next appointments 2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery. Postoperative X-rays are measured precisely to determine the Tip-Apex Distance (TAD), the Parkers-Ratio, the Singh-Score and the Neck-Shaft-Angle of the injured and contralateral side. Rates of complications as cut-out and reoperation-rates are evaluated. All intra-operative complications are noted and included in the chart.

Conditions

Interventions

TypeNameDescription
DEVICEGamma Nail 3Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by Gamma Nail 3.
DEVICEPFNAPatients who have sustained an unstable pertrochanteric hip fracture are getting treated by PFNA.

Timeline

Start date
2007-10-01
Primary completion
2010-12-01
Completion
2012-05-01
First posted
2014-03-03
Last updated
2014-03-03

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02074969. Inclusion in this directory is not an endorsement.

Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures (NCT02074969) · Clinical Trials Directory